DR info

Clinical trials : 5 / Drugs : 7 - (DrugBank : 5) / Drug target genes : 22 - Drug target pathways : 25

Fragile X syndrome related disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
205	Fragile X syndrome related disease	-
2	Amyotrophic lateral sclerosis	21.406
46	Malignant rheumatoid arthritis	21.389
13	Multiple sclerosis/Neuromyelitis optica	21.319
18	Spinocerebellar degeneration	20.651
3	Spinal muscular atrophy	20.456
70	Spinal stenosis	20.240
97	Ulcerative colitis	19.766
96	Crohn disease	19.706
6	Parkinson disease	19.669
21	Mitochondrial disease	19.141
206	Fragile X syndrome	18.947
17	Multiple system atrophy	18.797
5	Progressive supranuclear palsy	18.726
156	Rett syndrome	18.556
8	Huntington disease	18.480
75	Cushing disease	17.290
145	West syndrome	16.320
152	PCDH19 related syndrome	16.000
201	Angelman syndrome	14.429
84	Sarcoidosis	14.066
98	Eosinophilic gastrointestinal disease	13.816
272	Fibrodysplasia ossificans progressiva	13.785
296	Biliary atresia	13.615
22	Moyamoya disease	13.531
155	Acquired aphasia with convulsive disorder	13.418
193	Prader-Willi syndrome	13.373
298	Hereditary pancreatitis	13.305
231	Alpha-1-antitrypsin deficiency	12.873
158	Tuberous sclerosis	12.873
140	Dorabe syndrome	12.160
36	Epidermolysis bullosa	12.121
144	Lennox-Gastaut syndrome	12.121
34	Neurofibromatosis	11.299
78	Hypopituitarism	2.762
113	Muscular dystrophy	2.558
203	22q11.2 deletion syndrome	2.429
49	Systemic lupus erythematosus	2.269
127	Frontotemporal lobar degeneration	2.124
215	Tetralogy of Fallot	2.111
4	Primary lateral sclerosis	2.053
85	Idiopathic interstitial pneumonia	1.716
220	Rapidly progressive glomerulonephritis	1.000
30	Distal myopathy	1.000